Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-758-8 | CAS number: 150-38-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Refer to analogue justification provided in IUCLID section 13.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- BASF-TEST: In principle, the methods described in the OECD Guideline 401 were used. Young adult laboratory rats were purchased from breeder. Several groups of 10 rats per sex and dose were treated simultaneously by gavage with preparations of the test substance in suitable vehicle. The concentrations of these preparations were used to achieve comparable volumes per kg body weight. Group-wise documentation of clinical signs was performed over the 14 day study period. Body weight was determined before the start of the study as well as after day 2, 5, 7 and 13.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. K. Thomae GmbH, Biberach, Germany
- Weight at study initiation:
1210 mg/kg bw: 179 g males/178 g females
1780 mg/kg bw: 188 g males/180 g females
2000 mg/kg bw: 180 g males/182 g females
2610 mg/kg bw: 188 g males/187g females
- Housing: 5 animals per cage
- Diet: Ssniff R, ad libitum
- Water: ad libitum
- Acclimation period: at least one week
- Fasting period before study: 16 h
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24 °C
- Humidity (%): 30 - 70%
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- DOSAGE PREPARATION
- Stock solutions prepared:
12.1% for the 1210 mg/kg bw dose group
17.8% for the 1780 mg/kg bw dose group
20.0% for the 2000 mg/kg bw dose group
26.1% for the 2610 mg/kg bw dose group
DOSE VOLUME APPLIED:
10 mL/kg bw - Doses:
- 1210 mg/kg bw; 1780 mg/kg bw; 2000 mg/kg bw; 2610 mg/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Frequency of weighing: prior to the start of the experiment and on day 2, 5, 7, 13
- Necropsy of survivors performed: yes - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 780 - < 2 000 mg/kg bw
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 913 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 780 mg/kg bw
- Mortality:
- No mortalities were observed in the lowest dose group. At 2000 mg/kg bw all females and 7/10 males died (see table 1). In the highest dose group still half of the males survived.
- Clinical signs:
- other: 1210 mg/kg bw: no effects 1780 mg/kg bw: males dyspnea, apathy, ataxia, shaggy fur, poor general state; fully reversible within 5 days /females dyspnea, apathy, ataxia, abnormal positions, spastic gait, exiccosis, diarrhea, shaggy fur, saliva, poor genera
- Gross pathology:
- Animals that died:
stomach: redness and/or bloody ulceration of the glandular part of the stomach, redness of the mucous membrane, general hyperemia
gut: atonic, redness of the mucous membrane, bloody mucous content, general hyperemia
Animals which were sacrificed:
nothing abnormal detected - Interpretation of results:
- other: CLP/GHS criteria met; classification required as Acute Tox. 4, H302 according to Regulation (EC) No. 1272/2008
- Conclusions:
- In this acute oral toxicity study in rats the combined LD50 for male and female rats for the source substance tetrasodium dihydrogen EDTA was determined to be > 1780 < 2000 mg/kg bw. For this substance there exists also a CLP harmonized classification as Acute Tox. 4, H302.
Table 1: Mortalities of rats after oral application of Na4EDTA
1210 mg/kg bw | 1780 mg/kg bw | 2000 mg/kg bw | 2610 mg/kg bw | ||
1 h | male | 0/10 | 0/10 | 3/10 | 0/10 |
female | 0/10 | 0/10 | 1/10 | 6/10 | |
24 h | male | 0/10 | 2/10 | 7/10 | 5/10 |
female | 0/10 | 4/10 | 10/10 | 10/10 | |
48 h | male | 0/10 | 2/10 | 7/10 | 5/10 |
female | 0/10 | 4/10 | 10/10 | 10/10 | |
7 d | male | 0/10 | 2/10 | 7/10 | 5/10 |
female | 0/10 | 4/10 | 10/10 | 10/10 | |
14 d | male | 0/10 | 2/10 | 7/10 | 5/10 |
female | 0/10 | 4/10 | 10/10 | 10/10 |
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to OECD 401 guideline study with acceptable restrictions [Body weight was only determined at the beginning of the study (OECD: weekly); Observation period: 7 days (OECD:14 days)]
- Principles of method if other than guideline:
- BASF-TEST: In principle, the methods described in the OECD Guideline 401 were used. Young adult laboratory rats were purchased from breeder. Usually the source and strain of animals were not documented. Several groups of 5 rats per sex and dose were treated simultaneously by gavage with preparations of the test substance in suitable vehicle. The concentrations of these preparations were used to achieve comparable volumes per kg body weight. Group-wise documentation of clinical signs was performed over the 7 day study period. Body weight was determined before the start of the study only, as it was needed for determination of dose
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Mean body weight at study initiation:
259 g males/ 211 g females - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- DOSAGE PREPARATION:
- Stock solutions prepared: 30 %
- Dose volume applied: 2500 mg/kg bw dose group:
8.33 mL/kg bw
3200 mg/kg bw dose group: 10.66 mL/kg bw
4000 mg/kg bw dose group: 13.33 mL/kg bw
5000 mg/kg bw dose group: 16.66 mL/kg bw
6400 mg/kg bw dose group: 21.4 mL/kg bw - Doses:
- 2500; 3200; 4000; 5000; 6400 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days;
- The animals were observed for mortality and clinical signs of toxicity;
- Frequency of observations: Several times on the application day, thereafter once each working day;
- Body weights were only recorded at the beginning of the study;
- Necropsy of survivors and animals which died performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 800 mg/kg bw
- Mortality:
- - One female died in the 2500 mg/kg bw dose group; 9/10 animals died in the 3200 mg/kg bw dose group and all animals of the higher dose groups (see "Any other information on results incl. tables").
- Clinical signs:
- other: - 2500, 3200 and 4000 mg/kg bw: directly after application: accelerated respiration, squatting posture, twitching, ataxia, red eyes, some animals showed light secretion, reluctance to move; the next day: squatting posture, contaminated fur, intermittened
- Gross pathology:
- Animals which died:
- heart: acute dilatation, venous hyperemia
- liver: congestion
- gut: diarrhea like content
- stomach: dilatation
- kidneys: degeneration
Animals which were sacrificed:
- nothing abnormal detected - Interpretation of results:
- other: CLP/GHS criteria not met; no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- In this acute oral toxicity study performed, single doses of 2500, 3200, 4000, 5000 and 6400 mg/kg bw disodium hydrogen EDTA were administered by gavage to male and female rats as 30% solution in carboxymethyl cellulose solution. The dose groups consisted of 5 males and 5 females each and the animals were observed for 7 days. The LD50 was found to be 2800 mg/kg bw.
Table 1: Mortalities of rats after oral application
2500 mg/kg bw | 3200 mg/kg bw | 4000 mg/kg bw | 5000 mg/kg bw | 6400 mg/kg bw | ||
1 h | male | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
female | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | |
24 h | male | 0/5 | 3/5 | 5/5 | 5/5 | 5/5 |
female | 1/5 | 5/5 | 5/5 | 5/5 | 5/5 | |
48 h | male | 0/5 | 3/5 | 5/5 | 5/5 | 5/5 |
female | 1/5 | 5/5 | 5/5 | 5/5 | 5/5 | |
7 d | male | 0/5 | 4/5 | 5/5 | 5/5 | 5/5 |
female | 1/5 | 5/5 | 5/5 | 5/5 | 5/5 |
- Reason / purpose for cross-reference:
- reference to other study
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Remarks:
- only LD50 values stated
- Guideline:
- other: no information available
- Species:
- rat
- Route of administration:
- oral: unspecified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- >= 4 000 - <= 8 000 mg/kg bw
- Interpretation of results:
- other: CLP/GHS criteria not met; no classification required according to Regulation (EC) No. 1272/2008
Data source
Materials and methods
Test material
- Reference substance name:
- Trisodium hydrogen ethylenediaminetetraacetate
- EC Number:
- 205-758-8
- EC Name:
- Trisodium hydrogen ethylenediaminetetraacetate
- Cas Number:
- 150-38-9
- Molecular formula:
- C10H16N2O8.3Na
- IUPAC Name:
- trisodium hydrogen 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
Constituent 1
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 780 - < 2 000 mg/kg bw
- Remarks on result:
- other: source: CAS 64-02-8, BASF AG, 1983, rat
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 913 mg/kg bw
- Remarks on result:
- other: source: CAS 64-02-8, BASF AG, 1983, rat
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 780 mg/kg bw
- Remarks on result:
- other: source: CAS 64-02-8, BASF AG, 1983, rat
Any other information on results incl. tables
In an acute oral toxicity study performed with the read-across substance disodium hydrogen EDTA (CAS 139 -33 -3) by BASF (1973), single doses of 2500, 3200, 4000, 5000 and 6400 mg/kg bw Na2EDTA were administered by gavage to male and female rats as 30% solution in carboxymethyl cellulose solution. The dose groups consisted of 5 males and 5 females each and the animals were observed for 7 days. The LD50 was found to be 2800 mg/kg bw. Clinical symptoms were accelerated respiration, squatting posture, contaminated fur, intermittened respiration, reluctance to move. Autopsy of animals which died revealed dilatation of the heart and stomach as well as diarrhoea like content in the gut, congestion of the liver and degeneration of the kidney. The animals which were sacrificed showed no abnormalities during necropsy. For reasons of a conservative (worst case) assessment approach data these data were not used for risk assessment and classification.
An LD50 in rats of >= 4000 - <= 8000 mg/kg bw was determined for the target substance trisodium EDTA (cited in CIR, 2002). However, as no further details on the study design were available, this information was not considered for classification/non-classification.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/GHS criteria met; classification required as Acute Tox. 4, H302 according to Regulation (EC) No. 1272/2008
- Conclusions:
- An acute oral toxicity study in rats with the source substance tetrasodium EDTA (CAS 64-02-8) was selected as key result for reasons of structural similarity, data reliability and for reasons of a conservative (worst case) risk assessment approach.
The read across approach is justified in the analogue justification. The target and source substances are considered unlikely to differ in their acute oral toxicity potential. The combined LD50 for male and female rats for the source substance tetrasodium EDTA was determined to be > 1780 < 2000 mg/kg bw. For this substance (CAS 64-02-8) there exists also a CLP harmonized classification as Acute Tox. 4, H302. Therefore, an acute toxicity potential is also expected for the target substance trisodium hydrogen EDTA (CAS 150-38-9).
CLP: Acute Tox. 4, H302
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.